A new study shows a decreased PAC1 receptor expression in basal ganglia in a macaque model of PD (Feher et al., 2018), suggesting that reduced PACAP function contributes to neurodegeneration and PACAP might become a promising tool for PD therapy (Reglodi et al., 2017). The gene discussed is ADCYAP1R1; the disease is Parkinson disease.